Monday, December 12, 2016

BRIEF-Kalobios completes meeting with FDA for benznidazole

* Kalobios Pharmaceuticals-recently completed meeting with

U.S. FDA to review its proposed development plans for

benznidazole

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)